Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Early research (Phase 1)Study completedNCT00516438
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Who this might be right for
Malignant Solid Tumors
AstraZeneca 48
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Early research (Phase 1)UnknownNCT05539157
What this trial is testing

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Who this might be right for
Cutaneous TumorMalignant Solid Tumor
Immorna Biotherapeutics, Inc. 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715281
What this trial is testing

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Who this might be right for
Advanced Rare Malignant Solid NeoplasmRare Malignant Solid NeoplasmRefractory Rare Malignant Solid Neoplasm
National Cancer Institute (NCI) 12
Early research (Phase 1)Ended earlyNCT00801151
What this trial is testing

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Who this might be right for
Malignant Solid Tumour
Institut Claudius Regaud 30
Early research (Phase 1)Study completedNCT01023737
What this trial is testing

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
The University of Texas Health Science Center at San Antonio 72
Not applicableLooking for participantsNCT06562777
What this trial is testing

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
OHSU Knight Cancer Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Not applicableStudy completedNCT04694911
What this trial is testing

Development of the Oncology Opportunity Cost Assessment Tool

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 40
Early research (Phase 1)Study completedNCT00783328
What this trial is testing

PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Pfizer 13
Early research (Phase 1)Active Not RecruitingNCT02389309
What this trial is testing

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Brain NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT05144698
What this trial is testing

RAPA-201 Therapy of Solid Tumors

Who this might be right for
Solid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more
Rapa Therapeutics LLC 37
Testing effectiveness (Phase 2)Looking for participantsNCT07570563
What this trial is testing

Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.

Who this might be right for
Hematologic MalignancySolid Tumor
Chinese PLA General Hospital 24
Not applicableStudy completedNCT04889144
What this trial is testing

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 27
Early research (Phase 1)Study completedNCT00012181
What this trial is testing

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

Who this might be right for
Recurrent Childhood Brain Stem GliomaRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral Astrocytoma+19 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02717507
What this trial is testing

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 196
Early research (Phase 1)Study completedNCT01639911
What this trial is testing

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastCNS MalignancyMalignant Neoplasm of Gastrointestinal Tract+4 more
University of Illinois at Chicago 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07122063
What this trial is testing

Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 266
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Next Page